Home›Companies›Biotech & Pharma›BobcatBio

BobcatBio, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 12, 2025·Suggest an edit

About BobcatBio

BobcatBio is a private company based in Hummelstown, Pennsylvania, incorporated in 2020 in Delaware. It has reported $32,440,265 raised in two offerings on Form D since August 2021. Its chief executive is Stephen Rocamboli.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 26, 2025Mar 12, 2025$5,340,751of $15.0M target11$485KEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Jul 23, 2021Aug 5, 2021amended Jan 22, 2024$27,099,514of $42.0M target10$2.7MEquity, Options, Securities on exerciseRule 506(b)Form D/A ↗2 earlier filings
Total, two offerings$32,440,265

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on BobcatBio's Form D filed Mar 12, 2025.

RS
TT
Rifat Pamukcu
Rifat Pamukcu
Director
Also a chairperson of the board at Corami Biotech.
SR
Stephen Rocamboli
CEO and director

Earlier filings also listed John Fucci (director, last listed Jan 2024).

Sources

  1. SECBobcatBio, Inc. Form D/A, filed Nov 18, 2022
  2. SECBobcatBio, Inc. Form D, filed Aug 5, 2021
  3. SECBobcatBio, Inc. filing history